Ani Pharmaceuticals (ANIP) EBIT Margin (2011 - 2026)
Ani Pharmaceuticals (ANIP) posted EBIT Margin of 16.38% for Q1 2026, up 16.37% sequentially from 14.07% in Q4 2025, and up 309.0% YoY from 4.0% in Q1 2025.
Ani Pharmaceuticals (ANIP) EBIT Margin (2011 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported EBIT Margin for 16 years, with the latest figure at 16.38% in Q1 2026.
- Quarterly EBIT Margin rose 309.0% year-over-year to 16.38% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.4% (up 1244.0% YoY) and the FY2025 annual result came in at 12.58%, up 1248.0% from the prior year.
- EBIT Margin advanced to 16.38% in Q1 2026 per ANIP's latest filing, from 14.07% in the prior quarter.
- Over five years, EBIT Margin peaked at 16.38% in Q1 2026 and troughed at 29.77% in Q1 2022.
- A 5-year average of 3.29% and a median of 6.57% in 2025 frame the typical range for EBIT Margin.
- The widest YoY moves for EBIT Margin: up 4087 bps in 2022, down 5696 bps in 2022.
- Over 5 years, EBIT Margin stood at 1.93% in 2022, then jumped by 165 bps to 5.11% in 2023, then sank by 145 bps to 2.3% in 2024, then surged by 713 bps to 14.07% in 2025, then rose by 16 bps to 16.38% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 16.38%, 14.07%, and 15.91% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 15.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 15.21% |
| Mar 31, 2026 | 16.38% |
| Dec 31, 2025 | 14.07% |
| Sep 30, 2025 | 15.91% |
| Jun 30, 2025 | 6.57% |
| Mar 31, 2025 | 13.29% |
| Dec 31, 2024 | -2.30% |
| Sep 30, 2024 | -13.83% |
| Jun 30, 2024 | 3.74% |
| Mar 31, 2024 | 14.78% |
| Dec 31, 2023 | 5.11% |
| Sep 30, 2023 | 13.61% |
| Jun 30, 2023 | 10.64% |
| Mar 31, 2023 | 9.27% |
| Dec 31, 2022 | 1.93% |
| Sep 30, 2022 | -5.96% |
| Jun 30, 2022 | -17.48% |
| Mar 31, 2022 | -29.77% |
| Dec 31, 2021 | -38.94% |
| Sep 30, 2021 | -6.84% |